Clinical and Translational Medicine (May 2023)
CYTOR drives prostate cancer progression via facilitating AR‐V7 generation and its oncogenic signalling
- Jianpeng Yu,
- Tianyu Shen,
- Yang Li,
- Tangxi Hao,
- Long Yang,
- Hanlin Li,
- Xuan‐Mei Piao,
- Zheng Zhang,
- Shimiao Zhu,
- Changyi Quan,
- Wun‐Jae Kim,
- Yang Zhao,
- Yuanjie Niu,
- Zhiqun Shang
Affiliations
- Jianpeng Yu
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Tianyu Shen
- School of Medical Nankai University Tianjin China
- Yang Li
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Tangxi Hao
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Long Yang
- Department of Urology Tianjin Medical University General Hospital Tianjin China
- Hanlin Li
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Xuan‐Mei Piao
- Department of Urology, College of Medicine Chungbuk National University Cheongju Chungbuk South Korea
- Zheng Zhang
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Shimiao Zhu
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Changyi Quan
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Wun‐Jae Kim
- Department of Urology, College of Medicine Chungbuk National University Cheongju Chungbuk South Korea
- Yang Zhao
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Yuanjie Niu
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- Zhiqun Shang
- Tianjin Institute of Urology The Second Hospital of Tianjin Medical University Tianjin China
- DOI
- https://doi.org/10.1002/ctm2.1230
- Journal volume & issue
-
Vol. 13,
no. 5
pp. n/a – n/a
Abstract
No abstracts available.
